Metropolis Healthcare Limited Launches 5,200 sq. ft. New Laboratory in Kochi
February 05, 2021 at 12:18 am EST
Share
Metropolis Healthcare Ltd. announced the launch of a new laboratory in Kochi, Kerala. The 5,200 sq. ft. laboratory has the capability to conduct more than 30,000 sample testing per month including pathology tests ranging from basic pathology tests to high-end molecular diagnostic tests. The lab was inaugurated by Dr. T.V. Ravi, President, Indian Medical Association, Kochi. With 6,356 new cases detected in the state as on 3rd February 2021, Kerala is witnessing a resurgence in the COVID-19 cases with the UK virus variant also being detected in the state. Witnessing the rising need and demand to address the testing needs in the state, Metropolis Healthcare has further expanded its capabilities within the state, by launching this second bigger laboratory in Kochi. The new laboratory has the capability of conducting 30,000 tests per month. Metropolis Healthcare's expansion in Kerala also comes close to the recent announcement made to acquire a leading laboratory to strengthen its position in South India. It is also in line with its strategy to grow, gain market share and increase B2C revenues in focus cities in India.
Metropolis Healthcare Limited is an India-based company, which is engaged in providing diagnostic services. The Company operates through the pathology services segment. The Company offers a range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation, and monitoring of the disease. The Company also offers analytical and support services to clinical research organizations for their clinical research projects. Its services include pathology testing services, corporate wellness, lab in hospitals and clinical research services. The Company offers a range of tests and profiles that include advanced tests in diagnosis of cancer, neurological disorders, infectious diseases, and an array of genetic abnormalities. It owns a chain of diagnostic centers across India, South Asia, Africa, and the Middle East. The Company has spread its footprint across 20 Indian states and over 220 cities.